Frontier Capital Management CO LLC Crispr Therapeutics Ag Transaction History

Frontier Capital Management CO LLC

$9.58 Billion
Q2 2024

A detailed history of Frontier Capital Management CO LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 53,277 shares of CRSP stock, worth $2.52 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

53,277

Previous 102,098 47.82%

Holding current value

$2.52 Million

Previous $6.96 Million 58.65%

% of portfolio

0.03%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $2.5 Million - $3.33 Million	-48,821 Reduced 47.82%	53,277 $2.88 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $9.27 Million - $13.6 Million	-152,874 Reduced 59.96%	102,098 $6.96 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $392,495 - $733,565	-10,163 Reduced 3.83%	254,972 $16 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $5.02 Million - $6.53 Million	-110,653 Reduced 29.45%	265,135 $12 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $14.3 Million - $22.3 Million	329,441 Added 710.81%	375,788 $21.1 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $390,484 - $534,486	-9,524 Reduced 17.05%	46,347 $2.1 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $10.3 Million - $17.3 Million	-263,039 Reduced 82.48%	55,871 $2.27 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $9.19 Million - $12.6 Million	150,425 Added 89.28%	318,910 $20.8 Million
Q2 2022 Jul 20, 2022	BUY	$43.23 - $73.83 $889,154 - $1.52 Million	20,568 Added 13.91%	168,485 $10.2 Million
Q1 2022 Apr 14, 2022	BUY	$53.19 - $79.24 $7.87 Million - $11.7 Million	147,917 New	147,917 $9.29 Million
Q1 2021 May 13, 2021	SELL	$110.72 - $210.04 $352,753 - $669,187	-3,186 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$79.67 - $173.23 $79 - $173	-1 Reduced 0.03%	3,186 $488,000
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $12.3 Million - $15.7 Million	-156,271 Reduced 98.0%	3,187 $267,000
Q2 2020 Jul 17, 2020	BUY	$38.5 - $76.05 $1.71 Million - $3.37 Million	44,346 Added 38.52%	159,458 $11.7 Million
Q1 2020 Apr 16, 2020	BUY	$33.68 - $62.53 $1.3 Million - $2.41 Million	38,476 Added 50.21%	115,112 $4.88 Million
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $2.81 Million - $5.6 Million	76,636 New	76,636 $4.67 Million
Q3 2018 Oct 30, 2018	SELL	$44.35 - $65.71 $2.42 Million - $3.59 Million	-54,631 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$42.62 - $73.59 $2.33 Million - $4.02 Million	54,631 New	54,631 $3.21 Million

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.69B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account

Frontier Capital Management CO LLC Crispr Therapeutics Ag Transaction History